Oncology companies include Alligator Bioscience, Viracta Therapeutics, ImmunoCellular Therapeutics, VG Life Sciences, Eckert & Ziegler and 520 other companies.
Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients with viral-associated cancers and other serious diseases.
VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products.
Cellectar Biosciences (formerly Novelos Therapeutics) is a clinical biopharmaceutical company that focuses on the discovery, development, and commercialization of drugs for the treatment of cancer.
AIM ImmunoTech (formerly known as Hemispherx Biopharma) is an immuno-tech company focused on the research and development of immunological agents to treat multiple types of cancers and immune-deficiency diseases.
IN8Bio (formerly known as Innatus Therapeutics, Incysus Therapeutics) is a clinical-stage biopharmaceutical company focused on the development of gamma-delta T cell therapies for the treatment of cancer.